<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report successful treatment of a refractory <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>-associated <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum with the combination of thalidomide and interferon-alpha2a in a single patient </plain></SENT>
<SENT sid="1" pm="."><plain>A non-healing wound developed on a 40-year-old woman's left thumb after minor trauma </plain></SENT>
<SENT sid="2" pm="."><plain>Massive ulcerovegetative lesions developed after reconstruction surgery </plain></SENT>
<SENT sid="3" pm="."><plain>Histopathological examination of the bone marrow and cytogenetic studies revealed an atypical myeloproliferative/<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:mp ids='MP_0001212'>skin lesions</z:mp> resolved dramatically after two months of thalidomide and interferon-alpha2a combination therapy and the haematological status improved </plain></SENT>
</text></document>